Sufentanil Eurocept 5 microgram/ml clinical trials

(ROAR) Reversal of opioid-induced respiratory depression with opioid antagonists - a pharmacokinetic pharmacodynamic modeling study in opioid naïve individuals and chronic opioid users under real-life conditions

This study looks at how medicines called opioid antagonists can reverse breathing problems caused by strong painkillers (opioids). We're testing these medicines in healthy people and those who use opioids, to understand how quickly and effectively they work to help breathing.